| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.25 | 0.0002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.24 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 0.0009 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 0.002 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-10 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0007 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |